{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:16:37Z","timestamp":1778742997145,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jvir.2014.12.610","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T19:20:23Z","timestamp":1424805623000},"page":"723-732","source":"Crossref","is-referenced-by-count":20,"title":["Gene Expression in Hepatocellular Carcinoma: Pilot Study of Potential Transarterial Chemoembolization Response Biomarkers"],"prefix":"10.1016","volume":"26","author":[{"given":"Ron C.","family":"Gaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Groth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Parvinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh C.","family":"Casadaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2014.12.610_bib1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Disease. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2014.12.610_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00270-009-9766-5","article-title":"Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization","volume":"33","author":"Riaz","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jvir.2014.03.007","article-title":"Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study","volume":"25","author":"Stampfl","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1440-1746.2007.04997.x","article-title":"Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma","volume":"22","author":"Wu","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2014.12.610_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CAD.0b013e328346a0c5","article-title":"Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma","volume":"22","author":"Boulin","year":"2011","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jvir.2014.12.610_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jvir.2008.06.017","article-title":"Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors","volume":"19","author":"Virmani","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib8","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jvir.2014.12.610_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.5858\/2000-124-1061-IEOVEG","article-title":"Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis","volume":"124","author":"Park","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jvir.2014.12.610_bib10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1200\/JCO.2002.07.089","article-title":"Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study","volume":"20","author":"Poon","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2014.12.610_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jvir.2013.04.027","article-title":"The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice","volume":"24","author":"Marshall","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2014.12.610_bib13","first-page":"199","article-title":"Relevance network between chemosensitivity and transcriptome in human hepatoma cells","volume":"2","author":"Moriyama","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jvir.2014.12.610_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2009.04.009","article-title":"Hypoxia-specific gene expression for ischemic disease gene therapy","volume":"61","author":"Kim","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jvir.2014.12.610_bib15","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Hepatobiliary Cancers Version 2.2014 [cited 2014 November 16]. Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf. Accessed November 16, 2014."},{"key":"10.1016\/j.jvir.2014.12.610_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1051-0443(99)70117-X","article-title":"Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population","volume":"10","author":"Solomon","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2014.12.610_bib18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jhep.2011.03.007","article-title":"EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization","volume":"55","author":"Gillmore","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2014.12.610_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/1078-0432.CCR-12-0928","article-title":"Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer","volume":"19","author":"Brownell","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2014.12.610_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ejca.2007.01.004","article-title":"Prognostic molecular markers in hepatocellular carcinoma: a systematic review","volume":"43","author":"Mann","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2014.12.610_bib21","unstructured":"Affymetrix Product Spotlight: New QuantiGene 80 Plex Assay. Available from: http:\/\/www.panomics.com\/downloads\/80_plex_flyer.pdf. Accessed November 16, 2014."},{"key":"10.1016\/j.jvir.2014.12.610_bib22","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1051-0443(07)61789-8","article-title":"Chemoembolization of hepatocellular carcinoma","volume":"13","author":"Ramsey","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/108705710000500506","article-title":"Application of QuantiGene nucleic acid quantification technology for high throughput screening","volume":"5","author":"Warrior","year":"2000","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.jvir.2014.12.610_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physiolgenomics.00025.2005","article-title":"GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues","volume":"21","author":"Barber","year":"2005","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jvir.2014.12.610_bib25","first-page":"61","article-title":"Acute cell death in proliferating tissues in rats","volume":"27","author":"Philips","year":"1967","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvir.2014.12.610_bib26","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO;2-M","article-title":"Kinetics of mammary tumor cell growth and implications for therapy","volume":"28","author":"Skipper","year":"1971","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2014.12.610_bib27","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3748\/wjg.v10.i10.1533","article-title":"Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection","volume":"10","author":"Cui","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jvir.2014.12.610_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00129039-200209000-00004","article-title":"Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance","volume":"10","author":"Garcia","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jvir.2014.12.610_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ijc.23968","article-title":"TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance","volume":"124","author":"Wong","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jvir.2014.12.610_bib30","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jnci\/dji315","article-title":"A randomized phase III study of doxorubicin versus cisplatin\/interferon alpha-2b\/doxorubicin\/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma","volume":"97","author":"Yeo","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jvir.2014.12.610_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4161\/cbt.19295","article-title":"Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jvir.2014.12.610_bib32","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbrc.2013.12.095","article-title":"MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells","volume":"443","author":"Zhang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jvir.2014.12.610_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2007.03.018","article-title":"Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis","volume":"382","author":"Wu","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jvir.2014.12.610_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000111106","article-title":"Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma","volume":"72","author":"Rikimaru","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.jvir.2014.12.610_bib35","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/cncr.11266","article-title":"Expression and prognostic role of tumor suppressor gene PTEN\/MMAC1\/TEP1 in hepatocellular carcinoma","volume":"97","author":"Hu","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2014.12.610_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.510250321","article-title":"Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma","volume":"25","author":"Ueki","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2014.12.610_bib37","first-page":"436","article-title":"Diverse modes of genomic alterations in hepatocellular carcinoma","volume":"15","author":"Jhunjhunwala","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jvir.2014.12.610_bib38","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/1097-0142(19931215)72:12<3593::AID-CNCR2820721208>3.0.CO;2-T","article-title":"Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis","volume":"72","author":"Adachi","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2014.12.610_bib39","article-title":"Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma","author":"Zheng","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jvir.2014.12.610_bib40","doi-asserted-by":"crossref","first-page":"e93416","DOI":"10.1371\/journal.pone.0093416","article-title":"Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2014.12.610_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12032-014-0278-z","article-title":"Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients","volume":"31","author":"Zhang","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.jvir.2014.12.610_bib42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/cas.12428","article-title":"Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients","volume":"105","author":"Yuan","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jvir.2014.12.610_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12032-014-0267-2","article-title":"A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy","volume":"31","author":"Tang","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.jvir.2014.12.610_bib44","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jvir.2014.04.013","article-title":"Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"25","author":"Zhan","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2014.12.610_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-0034-1394137","article-title":"Molecular profiling of liver tumors: classification and clinical translation for decision making","volume":"34","author":"Pinyol","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2014.12.610_bib46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2014.12.610_bib47","unstructured":"QuantiGene 2.0 Assay: Overview. Available at http:\/\/www.panomics.com\/products\/gene-expression\/single-plex-assay\/overview. Accessed December 9, 2014."},{"key":"10.1016\/j.jvir.2014.12.610_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1756-0500-2-235","article-title":"RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts","volume":"2","author":"Vermeulen","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jvir.2014.12.610_bib49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2353\/jmoldx.2010.090155","article-title":"Quantitative expression profiling in formalin-fixed paraffin-embedded samples by Affymetrix microarrays","volume":"12","author":"Abdueva","year":"2010","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jvir.2014.12.610_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncponc0252","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"2","author":"McShane","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.jvir.2014.12.610_bib51","doi-asserted-by":"crossref","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","article-title":"Prognosis Research Strategy (PROGRESS) 2: prognostic factor research","volume":"10","author":"Riley","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jvir.2014.12.610_bib52","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044314018478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044314018478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T16:48:33Z","timestamp":1651337313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044314018478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1051044314018478"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2014.12.610","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}